Literature DB >> 21820142

Association between the severity of obstructive sleep apnea and the ratio of low-density lipoprotein cholesterol to high-density lipoprotein cholesterol.

Yoshiyuki Kawano1, Akira Tamura, Junichi Kadota.   

Abstract

The positive association between the ratio of serum low-density lipoprotein cholesterol (LDL-C) to serum high-density lipoprotein cholesterol (HDL-C) and cardiovascular events has recently been receiving much attention. However, the association between the severity of obstructive sleep apnea (OSA) and this ratio has not yet been investigated. Accordingly, we sought to clarify this association and the effect of continuous positive airway pressure (CPAP) therapy on the ratio. We performed polysomnography and LDL-C/HDL-C measurements in 215 patients who were suspected of having OSA. Furthermore, LDL-C/HDL-C was again evaluated 6 months after polysomnography in 30 OSA patients for whom CPAP therapy was initiated and continued, and in 11 age- and sex-matched OSA patients for whom the therapy could not be initiated. The LDL-C/HDL-C correlated positively with apnea-hypopnea index (ρ = 0.28, P < .001) and negatively with the lowest arterial oxyhemoglobin saturation (ρ = -0.30, P < .001). Multivariate regression analysis revealed that ln apnea-hypopnea index (or ln lowest arterial oxyhemoglobin saturation) was independently associated with LDL-C/HDL-C. The LDL-C/HDL-C decreased after 6 months in the CPAP group (2.29 ± 0.67 to 2.11 ± 0.74, P = .02), whereas it did not change in the non-CPAP group (2.65 ± 0.82 to 2.62 ± 0.66, P = .81). The severity of OSA was independently associated with LDL-C/HDL-C, and LDL-C/HDL-C was significantly reduced at 6 months after CPAP therapy. These findings suggest that LDL-C/HDL-C increases in proportion to the severity of OSA, which may contribute partly to an increased risk for cardiovascular events in OSA patients.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21820142     DOI: 10.1016/j.metabol.2011.06.004

Source DB:  PubMed          Journal:  Metabolism        ISSN: 0026-0495            Impact factor:   8.694


  8 in total

1.  Abnormalities of lipoprotein concentrations in obstructive sleep apnea are related to insulin resistance.

Authors:  Alice Liu; James Cardell; Danit Ariel; Cindy Lamendola; Fahim Abbasi; Sun H Kim; Tyson H Holmes; Vanessa Tomasso; Hafasa Mojaddidi; Kaylene Grove; Clete A Kushida; Gerald M Reaven
Journal:  Sleep       Date:  2015-05-01       Impact factor: 5.849

2.  Downregulation of uncoupling protein-1 mRNA expression and hypoadiponectinemia in a mouse model of sleep apnea.

Authors:  Cintia Zappe Fiori; Denis Martinez; Diego Baronio; Darlan Pase da Rosa; Nelson Alexandre Kretzmann; Luiz Felipe Forgiarini; Carolina Caruccio Montanari; Norma Possa Marroni; Alicia Carissimi
Journal:  Sleep Breath       Date:  2013-12-14       Impact factor: 2.816

Review 3.  Quintessential risk factors: their role in promoting cognitive dysfunction and Alzheimer's disease.

Authors:  Mak Adam Daulatzai
Journal:  Neurochem Res       Date:  2012-08-12       Impact factor: 3.996

4.  Catestatin serum levels are increased in male patients with obstructive sleep apnea.

Authors:  Josip A Borovac; Zoran Dogas; Daniela Supe-Domic; Tea Galic; Josko Bozic
Journal:  Sleep Breath       Date:  2018-08-07       Impact factor: 2.816

5.  Sleep apnoea in Australian men: disease burden, co-morbidities, and correlates from the Australian longitudinal study on male health.

Authors:  Chamara Visanka Senaratna; Dallas R English; Dianne Currier; Jennifer L Perret; Adrian Lowe; Caroline Lodge; Melissa Russell; Sashane Sahabandu; Melanie C Matheson; Garun S Hamilton; Shyamali C Dharmage
Journal:  BMC Public Health       Date:  2016-10-31       Impact factor: 3.295

Review 6.  Recent Advances in Studies on the Role of Neuroendocrine Disorders in Obstructive Sleep Apnea-Hypopnea Syndrome-Related Atherosclerosis.

Authors:  Wanda Wang; Yanli Zheng; Meimei Li; Shu Lin; Huili Lin
Journal:  Nat Sci Sleep       Date:  2021-07-27

7.  Pathobiology of obstructive sleep apnea-related dyslipidemia: focus on the liver.

Authors:  Aibek E Mirrakhimov; Alaa M Ali
Journal:  ISRN Cardiol       Date:  2013-01-02

8.  Decrease of perforin positive CD3+γδ-T cells in patients with obstructive sleep disordered breathing.

Authors:  Richard Staats; Raquel Rodrigues; André Barros; Leonor Bacelar-Nicolau; Margarida Aguiar; Dina Fernandes; Susana Moreira; André Simões; Bruno Silva-Santos; João Valença Rodrigues; Cristina Barbara; António Bugalho de Almeida; Luis Ferreira Moita
Journal:  Sleep Breath       Date:  2017-12-15       Impact factor: 2.816

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.